Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

The safety and efficacy of gemcitabine and concurrent radiation to the upper abdomen followed by weekly gemcitabine in patients with resected pancreatic cancer was determined. Patients with resected adenocarcinoma of the pancreas were treated with intravenous gemcitabine administered twice-weekly (4...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackstock, A W, Mornex, F, Partensky, C, Descos, L, Case, L D, Melin, S A, Levine, E A, Mishra, G, Limentani, S A, Kachnic, L A, Tepper, J E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360633/
https://www.ncbi.nlm.nih.gov/pubmed/16868545
http://dx.doi.org/10.1038/sj.bjc.6603270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360633/
https://www.ncbi.nlm.nih.gov/pubmed/16868545
http://dx.doi.org/10.1038/sj.bjc.6603270

Ejemplares similares